Enjoy complimentary customisation on priority with our Enterprise License!
The vitamin D3 market share is expected to increase by USD 928.48 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.95%.
This vitamin D3 market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by application (functional nutrition, pharmaceutical, and others) and geography (North America, Europe, Asia, and ROW). The vitamin D3 market report also offers information on several market vendors, including Amway Corp., BASF SE, Dishman Carbogen Amcis Ltd., Divis Laboratories Ltd., Fermenta Biotech Ltd., Koninklijke DSM NV, Lycored Corp., Xiamen Jindawei Group Co. Ltd., Zhejiang Garden Biochemical Hightech Co. Ltd., and Zhejiang Xianju Pharmaceutical Co. Ltd. among others.
Download the Free Report Sample to Unlock the Vitamin D3 Market Size for the Forecast Period and Other Important Statistics
The increasing geriatric population is notably driving the vitamin D3 market growth, although factors such as lack of awareness and limited healthcare services in developing regions may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic's impact on the vitamin D3 industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Vitamin D3 Market Driver
Globally, there has been a gradual increase in the geriatric population. Individuals over 50 years and above are at increased risk of vitamin D deficiency, as they lose a certain ability to synthesize vitamin D from sunlight. Older people confined at their homes have reduced outdoor activity; thereby, they lose their ability to obtain vitamin D through natural sunlight. Vitamin D deficiency in the geriatric population may lead to osteoporosis, muscle weakness, hip fractures, diabetes, cancer, cardiovascular disease, arthritis, and poor general health. This will drive growth in the global vitamin D3 market.
Key Vitamin D3 Market Challenge
There is a lack of awareness and limited healthcare services in developing regions. High-quality diagnostic tests, including vitamin D3 testing, are readily available and affordable in most developed countries. However, they are not easily affordable or accessible in developing countries, wherein the disease burden is high. The availability of food sources rich in vitamin D is limited and unaffordable in developing countries, contributing to low levels of vitamin D3 in the population. In addition, the low awareness among people regarding the intake of additional vitamin D3 supplements poses a challenge in providing proper nutrition to the required people.
This vitamin D3 market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the vitamin D3 market encompasses successful business strategies deployed by the key vendors. The vitamin D3 market is fragmented, and the vendors are deploying various organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments while maintaining their positions in the slow-growing segments.
The vitamin D3 market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
For more insights on the market share of various regions Request for a FREE sample now!
38% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for vitamin D3 in North America. Market growth in this region will be faster than the growth of the market in ROW.
A significant increase in pneumonia and respiratory tract infections due to low vitamin D levels will facilitate the vitamin D3 market's growth in North America during the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
To gain further insights on the market contribution of various segments Request for a FREE sample
The vitamin D3 market share growth by the functional nutrition segment will be significant during the forecast period. Functional nutrition is the holistic approach to diet, taking into consideration one's lifestyle factors that could affect their food choices, such as activity levels, environment, or the presence of chronic disease. A functional nutrition approach requires dieticians to follow a sequence of steps to determine what dietary changes their client will best benefit from. Functional nutrition understands the importance of vitamin deficiencies in a person. As a result, the demand for vitamin D3 will increase in the functional nutrition segment during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the vitamin D3 market size and actionable market insights on the post-COVID-19 impact on each segment.
You may be interested in:
Vitamin D market share is expected to increase by USD 2.34 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 13.35%.
Vitamin D3 Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.95% |
Market growth 2022-2026 |
USD 928.48 million |
Market structure |
Fragmented |
YoY growth (%) |
6.23 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 38% |
Key consumer countries |
US, Canada, Germany, China, UK, and The Netherlands |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Amway Corp., BASF SE, Dishman Carbogen Amcis Ltd., Divis Laboratories Ltd., Fermenta Biotech Ltd., Koninklijke DSM NV, Lycored Corp., Xiamen Jindawei Group Co. Ltd., Zhejiang Garden Biochemical Hightech Co. Ltd., and Zhejiang Xianju Pharmaceutical Co. Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Application
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.